Anti-Snoring Appliances and Airway Manipulation in Patients Undergoing Anesthetic Sedation

NCT ID: NCT05748626

Last Updated: 2025-08-14

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-06

Study Completion Date

2023-10-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Would patients using an anti-snoring appliance intraoperatively require less airway manipulation, interventions, and rescue maneuvers during anesthetic sedation cases compared to those who do not? The investigators will use anti-snoring appliance devices (specifically the FDA approved Zyppah) to attempt to relieve tissue obstructions that cause snoring during sleep. The application of the devices to the body is less invasive than other common intraoperative rescue airway devices (e.g. nasal trumpets and oral airways) which are not designed to be patient specific.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Airway Obstruction Snoring Sedation Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled interventional trial
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group #1: Anti-snoring appliance

Group #1: Anti-snoring appliance (Zyppah) that will be utilized during their procedure.

Group Type EXPERIMENTAL

Anti-snoring device

Intervention Type DEVICE

For group 1, the study team will aid the subject in molding and preparing the device in the pre-operative area. They will wear the device throughout the entirety of the case.

Group #2: Control group, that will not utilize anti-snoring appliance

Group #2: Control group, that will not utilize (Zyppah) anti-snoring appliance during their procedure.

Group Type ACTIVE_COMPARATOR

No anti -snoring device during their procedure.

Intervention Type PROCEDURE

For group 2 there will be no anti snoring device used during the case.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Anti-snoring device

For group 1, the study team will aid the subject in molding and preparing the device in the pre-operative area. They will wear the device throughout the entirety of the case.

Intervention Type DEVICE

No anti -snoring device during their procedure.

For group 2 there will be no anti snoring device used during the case.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

No intervention

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients (age 18-89 years old)
* Undergoing procedures below the umbilicus requiring anesthetic sedation without an invasive airway
* a STOP-BANG (survey) score of 2 or greater.

Exclusion Criteria

* Patients who are unable to consent
* Non-English speaking
* Those requiring general anesthesia.
Minimum Eligible Age

18 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northwestern University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mahesh Vaidyanathan

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mahesh Vaidyanathan, MD,MBA

Role: PRINCIPAL_INVESTIGATOR

Northwestern Univesity

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Northwestern Memorial Hospital and Prentice Women's Hospital

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Lacquiere DA, Hodzovic I, Woollard A, Varvinskiy A, Chishti K, Hughes R. DAS 2015 guidelines for management of CICO. Br J Anaesth. 2016 Oct;117(4):532-533. doi: 10.1093/bja/aew285. No abstract available.

Reference Type RESULT
PMID: 28077547 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STU00218263

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Comfort of Proactive Sleep Apnea Therapy
NCT06144892 NOT_YET_RECRUITING NA
Swallowing in OSA & CPAP Intolerance
NCT06786117 ENROLLING_BY_INVITATION NA